Wei-Ping Zhou (Weiping Zhou)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Topics

Combination Therapy

Signaling Pathway

Hepatitis B Virus

Top Venues

British journal of cancer

Cell death discovery

Hepatology communications

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Dong-Yang Ding, Shu-Ya Jiang, Yun-Xi Zu, Yuan Yang, Xiao-Jie Gan, Sheng-Xian Yuan, Wei-Ping Zhou
Collagen in hepatocellular carcinoma: A novel biomarker and therapeutic target. Hepatology communications 8 (7) (2024)
Dapeng Sun, Wen Li, Dongyang Ding, Kunjiang Tan, Wenbin Ding, Zongyan Wang, Siyuan Fu, Guojun Hou, Wei-Ping Zhou, Fangming Gu
IL-17a promotes hepatocellular carcinoma by increasing FAP expression in hepatic stellate cells via activation of the STAT3 signaling pathway. Cell death discovery 10 (1) (2024)
Dong-Yang Ding, Shu-Ya Jiang, Yun-Xi Zu, Yuan Yang, Xiao-Jie Gan, Sheng-Xian Yuan, Wei-Ping Zhou
Collagen in hepatocellular carcinoma: A novel biomarker and therapeutic target. Hepatology communications 8 (7) (2024)
Dong-Yang Ding, Shu-Ya Jiang, Yun-Xi Zu, Yuan Yang, Xiao-Jie Gan, Sheng-Xian Yuan, Wei-Ping Zhou
Collagen in hepatocellular carcinoma: A novel biomarker and therapeutic target. Hepatology communications 8 (7) (2024)
Dapeng Sun, Wen Li, Dongyang Ding, Kunjiang Tan, Wenbin Ding, Zongyan Wang, Siyuan Fu, Guojun Hou, Wei-Ping Zhou, Fangming Gu
IL-17a promotes hepatocellular carcinoma by increasing FAP expression in hepatic stellate cells via activation of the STAT3 signaling pathway. Cell death discovery 10 (1) (2024)
Dapeng Sun, Wen Li, Dongyang Ding, Kunjiang Tan, Wenbin Ding, Zongyan Wang, Siyuan Fu, Guojun Hou, Wei-Ping Zhou, Fangming Gu
IL-17a promotes hepatocellular carcinoma by increasing FAP expression in hepatic stellate cells via activation of the STAT3 signaling pathway. Cell death discovery 10 (1) (2024)
Qizhen Huang, Kongying Lin, Zhipeng Lin, Hongbin Ji, Xiaoyu Zhou, Bin Wang, Yufeng Chen, Chuandong Sun, Shuguo Zheng, Jinhong Chen, Yifan Wang, Yanming Zhou, Wei-Ping Zhou, Yongyi Zeng
Prognosis value of microscopic bile duct invasion in hepatocellular carcinoma: A multicenter study. Cancer medicine (2023)
Dapeng Sun, Xiaojie Gan, Lei Liu, Yuan Yang, Dongyang Ding, Wen Li, Junyao Jiang, Wenbin Ding, Linghao Zhao, Guojun Hou, Jian Yu, Jie Wang, Fu Yang, Sheng-Xian Yuan, Wei-Ping Zhou
DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334. Cell death & disease 13 (5) (2022)
Liqin Wang, Haojie Jin, Fleur Jochems, Siying Wang, Cor Lieftink, Isabel Mora Martinez, Giulia De Conti, Finn Edwards, Rodrigo Leite de Oliveira, Arnout Schepers, Yang-Yang Zhou, Jiaojiao Zheng, Wei Wu, Xingling Zheng, Shengxian Yuan, Jing Ling, Kathy Jastrzebski, Matheus Dos Santos Dias, Ji-Ying Song, Patrick N H Celie, Hideo Yagita, Ming Yao, Wei-Ping Zhou, Roderick L Beijersbergen, Wenxin Qin, René Bernards
cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis. Nature cancer 3 (11) (2022)
Dong-Yang Ding, Xiao-Jie Gan, Jia-Ning Zhang, Guo-Jun Hou, Qi-Fei Tao, Da-Peng Sun, Wen Li, Yuan Yang, Wen-Bin Ding, Jian Yu, Lei Liu, Fu Yang, Wei-Ping Zhou, Sheng-Xian Yuan
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma. British journal of cancer 128 (5) (2022)
Dong-Yang Ding, Xiao-Jie Gan, Jia-Ning Zhang, Guo-Jun Hou, Qi-Fei Tao, Da-Peng Sun, Wen Li, Yuan Yang, Wen-Bin Ding, Jian Yu, Lei Liu, Fu Yang, Wei-Ping Zhou, Sheng-Xian Yuan
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma. British journal of cancer 128 (5) (2022)
Dong-Yang Ding, Xiao-Jie Gan, Jia-Ning Zhang, Guo-Jun Hou, Qi-Fei Tao, Da-Peng Sun, Wen Li, Yuan Yang, Wen-Bin Ding, Jian Yu, Lei Liu, Fu Yang, Wei-Ping Zhou, Sheng-Xian Yuan
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma. British journal of cancer (2022)
Dong-Yang Ding, Xiao-Jie Gan, Jia-Ning Zhang, Guo-Jun Hou, Qi-Fei Tao, Da-Peng Sun, Wen Li, Yuan Yang, Wen-Bin Ding, Jian Yu, Lei Liu, Fu Yang, Wei-Ping Zhou, Sheng-Xian Yuan
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma. British journal of cancer 128 (5) (2022)
Dong-Yang Ding, Xiao-Jie Gan, Jia-Ning Zhang, Guo-Jun Hou, Qi-Fei Tao, Da-Peng Sun, Wen Li, Yuan Yang, Wen-Bin Ding, Jian Yu, Lei Liu, Fu Yang, Wei-Ping Zhou, Sheng-Xian Yuan
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma. British journal of cancer 128 (5) (2022)
Yun Yang, Kongying Lin, Lei Liu, Youwen Qian, Yuan Yang, Shengxian Yuan, Peng Zhu, Jian Huang, Fuchen Liu, Fangming Gu, Siyuan Fu, Beige Jiang, Hui Liu, Zeya Pan, Wan Yee Lau, Wei-Ping Zhou
Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis. Cancer medicine 10 (6) (2021)
Haojie Jin, Yaoping Shi, Yuanyuan Lv, Shengxian Yuan, Christel F A Ramirez, Cor Lieftink, Liqin Wang, Siying Wang, Cun Wang, Matheus Henrique Dias, Fleur Jochems, Yuan Yang, Astrid Bosma, E Marielle Hijmans, Marnix H P de Groot, Serena Vegna, Dan Cui, Yang-Yang Zhou, Jing Ling, Hui Wang, Yuchen Guo, Xingling Zheng, Nikita Isima, Haiqiu Wu, Chong Sun, Roderick L Beijersbergen, Leila Akkari, Wei-Ping Zhou, Bo Zhai, Wenxin Qin, René Bernards
EGFR activation limits the response of liver cancer to lenvatinib. Nature 595 (7869) (2021)
Jian Yu, Wen-Bing Ding, Meng-Chao Wang, Xing-Gang Guo, Jian Xu, Qing-Guo Xu, Yuan Yang, Shu-Han Sun, Jing-Feng Liu, Lun-Xiu Qin, Hui Liu, Fu Yang, Wei-Ping Zhou
Plasma circular RNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma: A large-scale, multicenter study. International journal of cancer 146 (6) (2019)